Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M124Revenue $M2.1Net Margin (%)-363.1Z-Score-5.7
Enterprise Value $M102EPS $-0.5Operating Margin %-366.4F-Score4
P/E(ttm))0Cash Flow Per Share $-0.4Pre-tax Margin (%)-366.3Higher ROA y-yN
Price/Book6.710-y EBITDA Growth Rate %0Quick Ratio9.9Cash flow > EarningsY
Price/Sales32.55-y EBITDA Growth Rate %0Current Ratio9.9Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-63.5Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-104.0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M29.3ROI % (ttm)-76.2Gross Margin Increase y-yN

Gurus Latest Trades with PSDV

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found!

PSDV is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


PSDV: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Ashton PaulPresident & CEO 2014-10-01Sell10,000$4.27-0.94 view
Ashton PaulPresident & CEO 2014-09-02Sell10,000$4.78-11.51 view
Ashton PaulPresident & CEO 2014-08-01Sell10,000$4.37-3.2 view
Ashton PaulPresident & CEO 2014-07-01Sell10,000$4.32-2.08 view
Ashton PaulPresident & CEO 2014-06-19Sell7,000$45.75 view
Ashton PaulPresident & CEO 2014-06-17Sell7,700$45.75 view
Freedman LoriVP Corp. Affairs, GC and Sec 2014-06-17Sell7,900$45.75 view
Freedman LoriVP Corp. Affairs, GC and Sec 2014-06-13Sell11,700$4.025.22 view
Ashton PaulPresident & CEO 2014-06-13Sell11,800$4.025.22 view
Ashton PaulPresident & CEO 2014-05-05Sell3,500$4.015.49 view

Press Releases about PSDV :

    Quarterly/Annual Reports about PSDV:

    News about PSDV:

    Articles On GuruFocus.com
    pSivida Ltd. Reports Operating Results (10-Q) Feb 10 2011 
    pSivida Ltd. Reports Operating Results (10-Q) Nov 09 2010 
    pSivida Ltd. Reports Operating Results (10-K) Sep 27 2010 
    pSivida Ltd. Reports Operating Results (10-Q) May 13 2010 
    pSivida Ltd. Reports Operating Results (10-Q) Feb 12 2010 
    pSivida Ltd. Reports Operating Results (10-Q) Nov 13 2009 
    pSivida Ltd. Reports Operating Results (10-K) Sep 25 2009 
    pSivida Ltd. Reports Operating Results (10-Q) May 13 2009 
    pSivida Ltd. Reports Operating Results (10-Q) Feb 11 2009 
    pSivida Corp. Reports Results for the Second Quarter Ended December 31, 2008; Iluvien™ NDA filing Feb 11 2009 

    More From Other Websites
    pSivida Corp – "FDA Approval of ILUVIEN(R) for DME: Company Reaches Inflection Point" Oct 06 2014
    PSIVIDA CORP. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Sep 30 2014
    Alimera, pSivida say FDA clears eye implant Sep 26 2014
    Why pSivida (PSDV) Stock Is Soaring in After-Hours Trading Today Sep 26 2014
    Alimera's eye implant Iluvien wins FDA approval Sep 26 2014
    pSivida Corp. Reports FDA Approval of ILUVIEN® for Diabetic Macular Edema Sep 26 2014
    PSIVIDA CORP. Files SEC form 8-K, Other Events Sep 25 2014
    PSIVIDA CORP. Financials Sep 18 2014
    PSIVIDA CORP. Files SEC form 8-K, Change in Directors or Principal Officers Sep 11 2014
    pSivida Corp. Names James Barry to Board of Directors Sep 10 2014
    PSIVIDA CORP. Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Sep 09 2014
    pSivida Corp. Reports Fourth Quarter and FY 2014 Results Sep 09 2014
    pSivida Corp. Reports Fourth Quarter and FY 2014 Results Sep 09 2014
    Q4 2014 pSivida Corp Earnings Release - After Market Close Sep 09 2014
    pSivida Corp Announces Fourth Quarter and Fiscal Year 2014 Financial Results Release Date and... Sep 03 2014
    pSivida Corp Announces Fourth Quarter and Fiscal Year 2014 Financial Results Release Date and... Sep 03 2014
    pSivida Corp. Reports ILUVIEN® for Chronic Diabetic Macular Edema Receives Marketing Authorization... Sep 03 2014
    pSivida Corp. Reports ILUVIEN® for Chronic Diabetic Macular Edema Receives Marketing Authorization... Sep 03 2014
    pSivida Corp. Reports ILUVIEN® for Chronic Diabetic Macular Edema Receives Marketing Authorization... Jul 31 2014
    pSivida Corp. Reports ILUVIEN® for Chronic Diabetic Macular Edema Receives Marketing Authorization... Jul 31 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK